132 related articles for article (PubMed ID: 2888909)
1. [Comparative studies on hemodynamic effects of intravenous cimetidine, ranitidine and famotidine in intensive care unit patients].
Omote K; Namiki A; Sumita S; Takahashi T; Ujike Y; Hagiwara T
Masui; 1987 Jun; 36(6):940-7. PubMed ID: 2888909
[No Abstract] [Full Text] [Related]
2. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
[TBL] [Abstract][Full Text] [Related]
3. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the hemodynamic effects of oral cimetidine, ranitidine, and famotidine as determined by echocardiography.
Welage LS; Dunn-Kucharski VA; Berardi RR; Shea MJ; Dechert RE; Bleske BE
Pharmacotherapy; 1995; 15(2):158-63. PubMed ID: 7624262
[TBL] [Abstract][Full Text] [Related]
6. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
7. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease.
Kedziora-Kornatowska K; Tkaczewski W; Blaszczyk J; Buczynski A; Chojnacki J; Kedziora J
Hepatogastroenterology; 1998; 45(19):276-80. PubMed ID: 9496526
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia.
Slichenmyer WJ; Donehower RC; Chen TL; Bowling MK; McGuire WP; Rowinsky EK
Cancer Chemother Pharmacol; 1995; 36(3):227-32. PubMed ID: 7781143
[TBL] [Abstract][Full Text] [Related]
9. [Cimetidine and ranitidine in intensive care patients. Double-blind randomized cross-over study on intravenous administration: hemodynamics, plasma coagulation, blood gases and acid-base status].
Breuer HW; Hartung HJ; Goeckenjan G; Abendroth RR; Curtius JM; Trampisch HJ; Kuntz BM; Loogen F
Dtsch Med Wochenschr; 1985 Jul; 110(30):1151-6. PubMed ID: 3893961
[TBL] [Abstract][Full Text] [Related]
10. Comparative study with ranitidine and cimetidine on gastric secretion.
Sewing KF; Billian A; Malchow H
Scand J Gastroenterol Suppl; 1981 Jun; 69():45-9. PubMed ID: 6119782
[TBL] [Abstract][Full Text] [Related]
11. 24 hour intragastric acidity and single night-time dose of three H-2-blockers.
Dammann HG; Müller P; Simon B
Lancet; 1983 Nov; 2(8358):1078. PubMed ID: 6138616
[No Abstract] [Full Text] [Related]
12. Long-term intravenous cimetidine treatment does not alter cortisol response in hemodynamically stable intensive care unit patients.
Spapen H; Diltoer M; De Wit N; Duinslaeger L; Huyghens L
Intensive Care Med; 1996 Feb; 22(2):175-6. PubMed ID: 8857128
[No Abstract] [Full Text] [Related]
13. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
14. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
15. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
[TBL] [Abstract][Full Text] [Related]
17. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine.
Oh T; Franko TG
Am J Hosp Pharm; 1990 Jul; 47(7):1547-51. PubMed ID: 2114789
[TBL] [Abstract][Full Text] [Related]
18. [Effects of H2 blockers on the spreading of macrophages in vitro].
Feder D; Bueno MA; Krybus J; Novak A; Martins MC; Andrade Júnior AF; Cabral M
Rev Paul Med; 1991; 109(5):213-6. PubMed ID: 1687946
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral H2-receptor antagonists on left ventricular systolic function and exercise capacity in patients with chronic stable heart failure.
Lucas BD; Williams MA; Mohiuddin SM; LaMadrid LJ; Schroeder LJ; Hilleman DE
Pharmacotherapy; 1998; 18(4):824-30. PubMed ID: 9692655
[TBL] [Abstract][Full Text] [Related]
20. Further evidence that brain histamine H2 receptors are stimulatory in the control of prolactin in the rat.
Netti C; Sibilia V; Guidobono F; Villa I; Franco P; Pecile A
Acta Endocrinol (Copenh); 1988 Dec; 119(4):488-92. PubMed ID: 2904722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
